Showing results (331-340 of 9,361) with videos related to

Sort By:
Pageof 937
The American Surgeon|April 1, 2025
Early Routine Lung Cancer Screening Leads to Improved Treatment Options and SurvivalJessica L Schweigert, Andrew J Borgert, Barbara A Bennie, et al.
Journal of Animal Physiology and Animal Nutrition|September 6, 2005
The efficacy of a modified aluminosilicate as a detoxifying agent in Fusarium toxin contaminated maize containing diets for pigletsS Döll, S Gericke, S Dänicke, et al.
Nutricion Hospitalaria|April 27, 2011
[Comparison between subjective and objective methods for sodium intake estimate among hypertensive persons]L B Dallepiane, I D Schweigert, T R L Bellé, et al.
European Journal of Medical Research|November 15, 2000
Neuropathy under chemotherapyT Beinert, F Masuhr, E Mwela, et al.
Current Medical Research and Opinion|August 22, 2008
Hemoglobin levels that trigger erythropoiesis-stimulating agent treatment decisions for cancer-associated anemia--examination of practice in GermanyT Steinmetz, U Totzke, U Söling, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery|February 25, 2022
Use of extracorporeal membrane oxygenation in non-elective major thoracic surgery for infectious lung abscessMichael Schweigert, Attila Dubecz, Carlos F Giraldo Ospina, et al.
Clinical Laboratory|October 23, 2002
Annexin V does not represent a diagnostic alternative to myoglobin for early detection of myocardial infarctionDirk Peetz, Gerd Hafner, Stefan Blankenberg, et al.
British Journal of Pharmacology|October 10, 2025
An intracellular recombinant single-chain variable antibody fragment as a new class of phosphodiesterase type 5 inhibitorsKürsat Kirkgöz, Sophie Sprenger, Olga Schweigert, et al.
Scientific Reports|November 22, 2016
Caenorhabditis elegans as a model system to study post-translational modifications of human transthyretinAndrea Henze, Thomas Homann, Isabelle Rohn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 16, 2001
The effect of increasing topotecan infusion from 30 minutes to 4 hours on the duration of exposure in cerebrospinal fluidW C Zamboni, D I Lüftner, M J Egorin, et al.
Pageof 937